4-Amino-2,6-dimethoxypyrimidine

We are 4-Amino-2,6-dimethoxypyrimidine CAS:3289-50-7 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests


Product Name: 4-Amino-2,6-dimethoxypyrimidine
Synonym: 2,6-Dimethoxypyrimidine-4-Amine; 6-Amino-2,4-dimethoxypyrimidine; Intermediate of Sulphadimethoxine
Cas No.: 3289-50-7
Formula: C6H9N3O2
MW: 155.15
EINECS No.:221-946-2

Density: 1.2±0.1 g/cm3
Boiling point: 340.1±45.0 °C at 760 mmHg
Melting point: 149-152 °C(lit.)
Flash point: 159.5±28.7 °C
Refractive index: 1.547

HS Code: 2933990099

UN No.: N.A
Hazard class: Not dangerous goods
 
Specification

Appearance: White crystal
Assay: ≥95%
Residue on ignition: ≤0.2%
Water: ≤0.5%

 
Application
Intermediate of Sulphadimethoxine.
 
Packaging
25 kg/barrel, can also be packaged according to customer requirements. 
 
Storage
Store in a cool, ventilated warehouse. 
Keep away from fire and heat. 
The temperature should not exceed 37 °C. 

4-Amino-2,6-dimethoxypyrimidine


Related News: Madeleine Roche, Associate Pharmaceutical Analyst at GlobalData, comments: “Within the top 20 global companies that spent the most on R&D in 2018, the top spender – despite having the second smallest annual revenue of the group at $15.28 billion – is Celgene, whose R&D spend was equal to 37% of its annual revenue.Dimethyl (3,3-difluoro-2-oxoheptyl)phosphonate CAS:50889-46-8 Madeleine Roche, Associate Pharmaceutical Analyst at GlobalData, comments: “Within the top 20 global companies that spent the most on R&D in 2018, the top spender – despite having the second smallest annual revenue of the group at $15.28 billion – is Celgene, whose R&D spend was equal to 37% of its annual revenue.89-25-8 At Day 35 following administration, a bone marrow assessment showed that FT819 persisted and continued to demonstrate tumor clearance, whereas primary CAR T cells, while persisting, were not able to control tumor growth.Diethyl 2,3-dichlorobutanedioate CAS:62243-26-9 At Day 35 following administration, a bone marrow assessment showed that FT819 persisted and continued to demonstrate tumor clearance, whereas primary CAR T cells, while persisting, were not able to control tumor growth.Under the high pressure of environmental protection, if Chinese API companies want to achieve sustainable operation, they must recognize the current situation, increase environmental investment, and carry out industrial upgrades, focusing on new product development, process improvement, CMO business and new technology research. And other businesses to carry out work to improve safety, environmental protection, quality, cost and other capabilities, so as to seize structural opportunities.

Related Products
Product Name
1H-Benzimidazole-2-methanol View Details
2-Methylphenyl isothiocyanate View Details
4-Amino-N-Boc-L-Phenylalanine View Details
Pentachlorobenzonitrile manufacturer 2-Chloro-4-(trifluoromethyl)pyridine manufacturer 1-Chloroethyl cyclohexyl carbonate manufacturer Ethanethioic acid S-ethyl ester manufacturer 1,2,3-Thiadiazol-5-amine manufacturer